Director Research and Development
Eurofins Viracor BioPharma Services
Mark Wissel is the Director of Research and Development at Eurofins Viracor BioPharma, where he is responsible for oversight of assay development & validation design and Scientific Advising. He led a restructure to improve quality and capacity as well as scientists’ career advancement opportunities. Dr. Wissel led molecular assay development projects, two of which led to clinical evaluations in high impact factor journal publications while supporting business development and client education. Dr. Wissel earned a PhD degree in Microbiology from the University of Iowa. With AAPS, he chairs multiple working groups as well as other volunteer roles. In addition he is a frequent speaker at national and international conferences typically related to Cell & Gene Therapy clinical trials testing. Dr. Wissel hopes to see the reach of high quality science expand to the benefit of many more patients. When he’s not doing science, he enjoys time outdoors with friends and family.